tyrosine kinase inhibitors news
Your Search Returned 119 tagged news reports
WageWorks to Present at the William Blair Growth Stock Conference
San Mateo :: CA :: USA | 14 days ago
Credibility
Consumer-Directed Benefits (CDBs), such as pretax accounts for health, commuter and other employee benefits, today announced its participation at the William Blair Growth Stock Conference on Tuesday, June 11, in Chicago. Joe Jackson, CEO, and Rich
Tags:
The Cancer Institute of New Jersey is One of 50 Sites in Nation to Offer COMET-2 Clinical Trial
Newark :: NJ :: USA | 14 days ago
Credibility
Researchers will compare results in patients receiving cabozantinib to those in patients who are receiving a standard treatment of mitoxantrone and prednisone for pain.
Tags:
Buy, Sell, or Hold: Exelixis
South San Francisco :: CA :: USA | 3 months ago
Credibility
When considering any stock for your portfolio, don't be swayed by just the positives. Examine its pros and cons, and decide whether it's possible upside outweighs its risks...Founded in 1994 and based in South San Francisco, Calif., Exelixis is a
Tags:
Exelixis makes Cometriq available in US
London :: United Kingdom | 5 months ago
Credibility
S Exelixis has announced the availability of Cometriq (cabozantinib), indicated for medullary thyroid cancer (MTC), in the US. Diplomat Specialty Pharmacy is distributing the product across the US...The receptor tyrosine kinases play a vital role in
Tags:
Genentech takes Exelixis drug into Phase III melanoma trial
South San Francisco :: CA :: USA | 5 months ago
Credibility
Exelixis Inc., giving the smaller biotech company the option to potentially co-promote the drug. Genentech, the South San Francisco-based biotech subsidiary of drug giant Roche, dosed the first patient Monday in the Phase III trial, Exelixis said in
Tags:
One Person's Trash Is Another Person's Treasure Selection: Dendreon
Brussels :: Belgium | 7 months ago
Credibility
Three weeks ago, I announced my intention to create a portfolio composed of 10 companies that investors have unjustly cast aside. My goal in creating the One Person's Trash Is Another Person's Treasure portfolio is to highlight just how successful
Tags:
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Vienna :: VA :: USA | 9 months ago
Credibility
Annual Meeting (Abstract #LBA28), which is taking place in Vienna, Austria...V600 mutation positive, unresectable locally advanced or metastatic melanoma. Study Design The Phase Ib dose escalation study was designed to evaluate the safety and
Tags:
Reading Between the FDA Lines
Alexandria :: VA :: USA | 10 months ago
Credibility
The FDA holds advisory committee meetings to get feedback from outside experts about whether they think a drug should be approved. The agency must have canceled the meeting for cabozantinib because it doesn't see a need to get outside input. Or, put
Tags:
PHARMAC funds new targeted lung cancer drug
Auckland :: New Zealand | 11 months ago
Credibility
Erlotinib is currently funded as a second-line treatment option...Where DHBs do not have the test they may send samples to Australia for testing. Medical Director Dr Peter Moodie says current first-line treatment for non-small cell lung cancer is
Tags:
Drug slows advanced prostate cancer
Chicago :: IL :: USA | 1 year ago
Credibility
A drug was so effective in slowing the spread of metastatic prostate cancer, that those taking the placebo were given the drug, U.S. researchers said...Ryan of the University of California, San Francisco's Helen Diller Family Comprehensive Cancer
Tags:
